Healthcare
5 evidence matches
Impact 100% Confidence 90%
Health
Health
Health programs administration and funding
HR 2820 - 114Stem Cell Therapeutic and Research Reauthorization Act of 2015
Became Public Law No: 114-104.
Bill Text Stats
Bill text analysis is not available for this record yet.
Affected Sectors
How to read this
Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.
Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.
Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.
Confidence is the strongest individual match score behind that sector.
Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.
Energy
1 evidence matches
Impact 91% Confidence 85%
Energy and Commerce Committee Standing House
CBO Cost Estimates
Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.
How to read this
CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.
LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.
CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.
CBO cost estimate
H.R. 2820, Stem Cell Therapeutic and Research Reauthorization Act of 2015
Dec 8, 2015
As ordered reported by the Senate Committee on Health, Education, Labor, and Pensions on November 18, 2015
View CBO source preview
CBO cost estimate
H.R. 2820, Stem Cell Therapeutic and Research Reauthorization Act of 2015
Aug 13, 2015
As ordered reported by the House Committee on Energy and Commerce on July 29, 2015
View CBO source preview
Campaign Finance Context
Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.
How to read this
Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.
They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.
If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.
Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.
No FEC/OpenFEC campaign-finance context is currently linked for this bill.
Lobbying Context
Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.
How to read this
LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.
A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.
Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.
No LDA.gov lobbying disclosure context is currently linked for this bill.
Summary
49 Public Law Apr 7, 2016
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.) Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. (Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
35 Passed Senate amended Apr 7, 2016
(This measure has not been amended since it was reported to the Senate on December 3, 2015. The summary of that version is repeated here.) Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. (Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
01 Reported to Senate with amendment(s) Mar 23, 2016
Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Sec. 2) This bill amends the Public Health Service Act and the Stem Cell Therapeutic and Research Act of 2005 to revise and extend through FY2020 the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory program. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.) The Department of Health and Human Services (HHS) must review the state of the science of using adult stem cells and birthing tissues to develop new therapies and consider the inclusion of new therapies in the C.W. Bill Young Cell Transplantation Program. (Sec. 3) Requirements for HHS contracts under the Stem Cell Therapeutic and Research Act of 2005 are revised. (Sec. 4) HHS must determine whether to include peripheral blood stem cells and umbilical cord blood in the definition of human organ.
81 Passed House without amendment Sep 15, 2015
(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.) Stem Cell Therapeutic and Research Reauthorization Act of 2015 (Sec. 2) This bill amends the Stem Cell Therapeutic and Research Act of 2005 to reauthorize the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program through FY2020. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
00 Introduced in House Jul 1, 2015
Stem Cell Therapeutic and Research Reauthorization Act of 2015 This bill amends the Stem Cell Therapeutic and Research Act of 2005 to reauthorize the National Cord Blood Inventory program and the C.W. Bill Young Cell Transplantation Program through FY2020. (These programs help match patients in need of a transplant with unrelated bone marrow and cord blood donors.)
Sponsors
CF
Website
N/A
Phone
N/A
Office
N/A
DJ
Website
N/A
Phone
N/A
Office
N/A
RG
Website
N/A
Phone
N/A
Office
N/A
TH
Website
N/A
Phone
N/A
Office
N/A
RE
Website
N/A
Phone
N/A
Office
N/A
TM
Website
N/A
Phone
N/A
Office
N/A
PD
Website
N/A
Phone
N/A
Office
N/A
AH
Website
N/A
Phone
N/A
Office
N/A
PR
Website
N/A
Phone
N/A
Office
N/A
LL
Website
N/A
Phone
N/A
Office
N/A
DN
Website
N/A
Phone
N/A
Office
N/A
RN
Website
N/A
Phone
N/A
Office
N/A
DR
Website
N/A
Phone
N/A
Office
N/A
LB
Website
N/A
Phone
N/A
Office
N/A
MB
Website
N/A
Phone
N/A
Office
N/A
AE
Website
N/A
Phone
N/A
Office
N/A
DL
Website
N/A
Phone
N/A
Office
N/A
Timeline
Dec 18, 2015
Presented to President.
Dec 18, 2015
Presented to President.
Dec 18, 2015
Signed by President.
Dec 18, 2015
Signed by President.
Dec 18, 2015
Became Public Law No: 114-104.
Dec 18, 2015
Became Public Law No: 114-104.
Dec 16, 2015
Mr. Pitts moved that the House suspend the rules and agree to the Senate amendment. (consideration: CR H9333-9335, H9339)
Dec 16, 2015
DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and concur in the Senate amendment to H.R. 2820.
Dec 16, 2015
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the chair announced that further proceedings on the motion would be postponed.
Dec 16, 2015
Resolving differences -- House actions: On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695).(text as House agreed to Senate amendment: CR H9333)
Dec 16, 2015
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by the Yeas and Nays: (2/3 required): 421 - 0 (Roll no. 695). (text as House agreed to Senate amendment: CR H9333)
Dec 16, 2015
Motion to reconsider laid on the table Agreed to without objection.
Dec 10, 2015
Message on Senate action sent to the House.
Dec 9, 2015
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.(consideration: CR S8560; text as passed Senate: CR S8560)
Dec 9, 2015
Passed Senate with an amendment by Unanimous Consent. (consideration: CR S8560; text as passed Senate: CR S8560)
Dec 3, 2015
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Dec 3, 2015
Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.
Dec 3, 2015
Placed on Senate Legislative Calendar under General Orders. Calendar No. 311.
Nov 18, 2015
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Sep 9, 2015
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 8, 2015
Reported by the Committee on Energy and Commerce. H. Rept. 114-242.
Sep 8, 2015
Reported by the Committee on Energy and Commerce. H. Rept. 114-242.
Sep 8, 2015
Placed on the Union Calendar, Calendar No. 183.
Sep 8, 2015
Mr. Guthrie moved to suspend the rules and pass the bill.
Sep 8, 2015
Considered under suspension of the rules. (consideration: CR H5801-5804)
Sep 8, 2015
DEBATE - The House proceeded with forty minutes of debate on H.R. 2820.
Sep 8, 2015
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H5801)
Sep 8, 2015
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5801)
Sep 8, 2015
Motion to reconsider laid on the table Agreed to without objection.
Jul 29, 2015
Committee Consideration and Mark-up Session Held.
Jul 29, 2015
Ordered to be Reported by Voice Vote.
Jul 23, 2015
Subcommittee Consideration and Mark-up Session Held.
Jul 23, 2015
Forwarded by Subcommittee to Full Committee by Voice Vote .
Jun 19, 2015
Referred to the Subcommittee on Health.
Jun 18, 2015
Introduced in House
Jun 18, 2015
Introduced in House
Jun 18, 2015
Referred to the House Committee on Energy and Commerce.
House Votes
No House roll call votes have been linked to this bill yet.
Amendments
No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.